City Office REIT(CIO)

Search documents
Drilling Commences
GlobeNewswire· 2025-05-01 12:13
VANCOUVER, British Columbia, May 01, 2025 (GLOBE NEWSWIRE) -- Central Iron Ore Limited (CIO – TSX.V) (“CIO” or “the Company”) is pleased to announce this Drilling Update. Central Iron Ore Limited is pleased to announce that the next phase of resource expansion drilling at the British King Project in Western Australia has commenced (Figure 1). 78 Reverse Circulation ('RC') drillholes are scheduled to be completed over a 9-week campaign. Figure 1. The sun sets after another successful day's drilling of the 2 ...
CIO vs. EGP: Which Stock Should Value Investors Buy Now?
ZACKS· 2025-04-16 16:46
Investors interested in REIT and Equity Trust - Other stocks are likely familiar with City Office REIT (CIO) and EastGroup Properties (EGP) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The proven Zacks Rank emphasizes companies with positive estimate revision trends, and our Style Scores h ...
Tevogen Bio CIO and Head of Tevogen.AI Presented at AI x Bio Philly Event Showcasing Philly's Leading AI Biotechs
GlobeNewswire News Room· 2025-04-08 21:53
Core Insights - Tevogen Bio Holdings Inc. is focused on immunotherapy and artificial intelligence, with recent presentations highlighting its AI-driven technology for T cell therapies [1][3] - The company aims to develop off-the-shelf, genetically unmodified precision T cell therapies to address significant unmet medical needs in infectious diseases and cancers [4][5] Company Overview - Tevogen Bio is a clinical-stage specialty immunotherapy company utilizing CD8+ cytotoxic T lymphocytes for therapeutic development [4] - The company has reported positive safety data from its proof-of-concept clinical trial and owns key intellectual property assets, including three granted patents and multiple pending patents related to artificial intelligence [4] Recent Events - Mittul Mehta, the Chief Information Officer, presented at the AI x Bio Philly event, discussing Tevogen.AI's proprietary technology that accelerates the discovery and development of precision T cell therapies [1][3][2] - The event gathered innovators and investors to explore the impact of AI on biotechnology, showcasing the convergence of these fields [2]
The CIO's Balancing Act: New Global Study Reveals How Tech Leaders Manage Security Threats While Driving Innovation
Prnewswire· 2025-04-08 14:01
MILWAUKEE, April 8, 2025 /PRNewswire/ -- More than four out of ten (41%) Chief Information Officers (CIOs) report cybersecurity as their top concern, yet these same leaders are simultaneously increasing security budgets (77%), expanding cloud infrastructure (68%), and accelerating artificial intelligence (AI) capabilities (67%). According to the new Future Forward: CIO 2025 Outlook report released today by Experis, a global leader in IT workforce solutions and part of the ManpowerGroup (NYSE: MAN) family of ...
Robert Half Honored by Fortune and CIO 100 for Excellence in Innovation
Prnewswire· 2025-03-27 16:05
Core Insights - Robert Half has been recognized as one of Fortune's 2025 America's Most Innovative Companies and has won the 2025 CIO 100 Award, highlighting its commitment to innovation and technology solutions [1][2] - The recognition is based on an extensive evaluation of product, process, and company culture, involving insights from over 45,000 U.S. employees across more than 3,000 companies [2] - The company emphasizes its investment in AI and technology to enhance recruitment processes and improve customer experiences [3][4] Company Achievements - Robert Half is the only company in its industry to receive the aforementioned accolades, showcasing its unique position in the market [1] - The company has also received a Stevie Award for 'Best Artificial Intelligence/Machine Learning Solution' for its AI capabilities that benefit clients, candidates, and employees [4] - In the past year, Robert Half has been named one of Fortune's Most Admired Companies and one of the 100 Best Companies to Work For [5] Technology and Innovation - The company utilizes AI-powered tools that leverage advanced machine learning and proprietary data to create real-time candidate shortlists and optimize client outreach [3] - Robert Half's technology initiatives significantly enhance its ability to connect top talent with challenging roles, thereby improving service delivery to customers [4] - The focus on innovation is embedded in the company's culture, as stated by its CEO, emphasizing the importance of providing a world-class experience for customers and empowering employees [3]
5 Low Price-to-Book Stocks to Include in Your Portfolio for Gains
ZACKS· 2025-03-26 12:50
When evaluating a company’s value, investors mostly look at the stock’s price-to-earnings (P/E) or price-to-sales (P/S) ratio. While P/E is the ratio of annual earnings to stock price, P/S reflects the amount investors pay for each dollar of revenues generated by the company.Though P/E and P/S valuation tools are more commonly used for stock selection, the price-to-book ratio (P/B ratio) is also an easy-to-use metric for identifying low-priced stocks with high-growth prospects.P/B is the ratio of stock pric ...
British King Gold Project: Filing of NI43-101 Technical Report
GlobeNewswire· 2025-03-20 11:00
VANCOUVER, British Columbia, March 20, 2025 (GLOBE NEWSWIRE) -- Central Iron Ore Limited. (CIO – TSX.V) (“CIO” or “the Company”) is pleased to announce that is has filed a National Instrument 43-101 Technical Report Mineral Resource Estimate, British King Gold Project Western Australia. CIO is pleased to announce that it has filed an independent technical report titled “Technical Report Mineral Resource Estimate, British King Gold Project Western Australia” prepared by Andrew Bewsher MAIG with an effective ...
Tevogen Bio's CIO & Head of Tevogen.AI, Mittul Mehta, Featured Speaker at Proskauer's AI Discussion Panel
GlobeNewswire News Room· 2025-03-07 21:09
Core Insights - Tevogen Bio is leveraging AI to enhance precision medicine and operational efficiencies in the biotech sector [2][3] - The company is focused on developing off-the-shelf, genetically unmodified precision T cell therapies to address significant unmet medical needs [5][6] Company Overview - Tevogen Bio is a clinical-stage specialty immunotherapy company utilizing CD8+ cytotoxic T lymphocytes for treating infectious diseases and cancers [5] - The company has reported positive safety data from its proof-of-concept clinical trial and owns key intellectual property assets, including three granted patents and multiple pending patents related to AI [5][6] Industry Context - The AI discussion panel highlighted the transformative impact of AI across finance, biotech, and legal sectors, emphasizing the need for tailored approaches to address unique industry challenges [2][3] - The event featured industry leaders discussing the latest advancements in AI and its applications in enhancing operational efficiencies [4]
Should Value Investors Buy City Office REIT (CIO) Stock?
ZACKS· 2025-03-03 15:46
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.Of these, value investing is easily one of the most popular ways to find great stocks in any market environment. Value investors use a variety of methods, including tried-an ...
City Office REIT(CIO) - 2024 Q4 - Earnings Call Presentation
2025-02-20 18:46
I N V E S T O R P R E S E NTATION F E B R U A R Y 2 0 2 5 N Y S E: CIO FORWARD-LOOKING STATEMENTS This presentation contains both historical and forward-looking statements. All statements, other than statements of historical fact are, or may be deemed to be, forward looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. We have used the words "approximately," "anticipate," "assume," "believe," "budge ...